Functional screening of serine protease inhibitors in the medical leech Hirudo medicinalis monitored by intensity fading MALDI-TOF MS

Molecular and Cellular Proteomics

Volumn 4, Issue 10, 2005, Pages 1602-1613

  Yanes, Oscar ^a   Villanueva, Josep ^a,b   Querol, Enrique ^a   Aviles, Francesc X ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIRUDIN; PEPTIDE; PROTEINASE; SERINE PROTEINASE INHIBITOR; TRYPSIN;

ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG DETERMINATION; INVERTEBRATE; LEECH; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SEPARATION TECHNIQUE; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; COMPLEX MIXTURES; HIRUDO MEDICINALIS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDES; PROTEIN BINDING; PROTEINS; REPRODUCIBILITY OF RESULTS; SEQUENCE HOMOLOGY, AMINO ACID; SERINE PROTEINASE INHIBITORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

HIRUDINIDA; HIRUDO MEDICINALIS; INVERTEBRATA;

EID: 27644567613     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500145-MCP200     Document Type: Article

References (53)

1. de Hoog, C. L., and Mann, M. (2004) Proteomics. Annu. Rev. Genomics Hum. Genet. 5, 267-293
2. Baggerman, G., Verleyen, P., Clynen, E., Huybrechts, J., De Loof, A., and Schoofs, L. (2004) Peptidomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 15, 3-16
3. Rill, R. L., and Al-Sayah, M. A. (2004) Peptide separations by slab gel electrophoresis in pluronic F127 polymer liquid crystals. Electrophoresis 25, 1249-1254
4. Southan, C. (2004) Has the yo-yo stopped? - an assessment of human protein-coding gene number. Proteomics 4, 1712-1726
5. Clynen, E., De Loof, A., and Schoofs, L. (2003) The use of peptidomics in endocrine research. Gen. Comp. Endocrinol. 132, 1-9
6. Schrader, M., and Schulz-Knappe, P. (2001) Peptidomics technologies for human body fluids. Trends Biotechnol. 19, Suppl. 10, S55-S60
7. Adermann, K., John, H., Standker, L., and Forssmann, W. G. (2004) Exploiting natural peptide diversity: novel research tools and drug leads. Curr. Opin. Biotechnol. 15, 599-606
8. Walsh, G. (1998) Biopharmaceuticals: Biochemistry and Biotechnology, John Wiley & Sons, New York
9. Schulz-Knappe, P., Zucht, H. D., Heine, G., Jurgens, M., Hess, R., and Schrader, M. (2001) Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb. Chem. High Throughput Screen. 4, 207-217
10. Jurgens, M., and Schrader, M. (2002) Peptidomic approaches in proteomic research. Curr. Opin. Mol. Ther. 4, 236-241
11. Audsley, N., and Weaver, R. J. (2003) A comparison of the neuropeptides from the retrocerebral complex of adult male and female Manduca sexta using MALDI-TOF mass spectrometry. Regul. Pept. 116, 127-137
12. Baggerman, G., Cerstiaens, A., De Loof, A., and Schoofs, L. (2002) Peptidomics of the larval Drosophila melanogaster central nervous system. J. Biol. Chem. 277, 40368-40374
13. Skold, K., Svensson, M., Kaplan, A., Bjorkesten, L., Astrom, J., and Andren, P. E. (2002) A neuroproteomic approach to targeting neuropeptides in the brain. Proteomics 2, 447-454
14. Heine, G., Raida, M., and Forssmann, W. G. (1997) Mapping of peptides and protein fragments in human urine using liquid chromatography mass spectrometry. J. Chromatogr. A 776, 117-124
15. Baggerman, G., Clynen, E., Huybrechts, J., Verleyen, P., Clerens, S., De Loof, A., and Schoofs, L. (2003) Peptide profiling of a single Locusta migratoria corpus cardiacum by nano-LC tandem mass spectrometry. Peptides 24, 1475-1485
16. Huybrechts, J., De Loof, A., and Schoofs, L. (2004) Diapausing Colorado potato beetles are devoid of short neuropeptide F I and II. Biochem. Biophys. Res. Commun. 317, 909-916
17. Rubakhin, S. S., Garden, R. W., Fuller, R. R., and Sweedler, J. V. (2000) Measuring the peptides in individual organelles with mass spectrometry. Nat. Biotechnol. 18, 172-175
18. Fenselau, C., and Demirev, P. A. (2001) Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom. Rev. 20, 157-171
19. Jimenez, C. R., Li, K. W., Dreisewerd, K., Spijker, S., Kingston, R., Bateman, R. H., Burlingame, A. L., Smit, A. B., van Minnen, J., and Geraerts, W. P. (1998) Direct mass spectrometric peptide profiling and sequencing of single neurons reveals differential peptide patterns in a small neuronal network. Biochemistry 37, 2070-2076
20. Jimenez, C. R., Li, K. W., Dreisewerd, K., Mansvelder, H. D., Brussaard, A. B., Reinhold, B. B., Van der Schors, R. C., Karas, M., Hillenkamp, F., Burbach, J. P., Costello, C. E., and Geraerts, W. P. (1997) Pattern changes of pituitary peptides in rat after salt-loading as detected by means of direct, semiquantitative mass spectrometric profiling. Proc. Natl. Acad. Sci. U. S. A. 94, 9481-9486
21. Li, L. J., Garden, R. W., and Sweedler, J. V. (2000) Single-cell MALDI: a new tool for direct peptide profiling. Trends Biotechnol. 18, 151-160
22. Figeys, D. (2002) Functional proteomics: mapping protein-protein interactions and pathways. Curr. Opin. Mol. Ther. 4, 210-215
23. Whitelegge, J. P., and le Coutre, J. (2001) Proteomics: making sense of genomic information for drug discovery. Am. J. Pharmacogenomics 1, 29-35
24. Pillutla, R. C., Goldstein, N. I., Blume, A. J., and Fisher, P. B. (2002) Target validation and drug discovery using genomic and protein-protein interaction technologies. Expert Opin. Ther. Targets 6, 517-531
25. Chanda, S. K., and Caldwell, J. S. (2003) Fulfilling the promise: drug discovery in the post-genomic era. Drug Discov. Today 8, 168-174
26. Serebriiskii, I. G., Mitina, O., Pugacheva, E. N., Benevolenskaya, E., Kotova, E., Toby, G. G., Khazak, V., Kaelin, W. G., Chernoff, J., and Golemis, E. A. (2002) Detection of peptides, proteins, and drugs that selectively interact with protein targets. Genome Res. 12, 1785-1791
27. Figeys, D. (2002) Proteomics approaches in drug discovery. Anal. Chem. 74, 413A-419A
28. Villanueva, J., Yanes, O., Querol, E., Serrano, L., and Aviles, F. X. (2003) Identification of protein ligands in complex biological samples using intensity-fading MALDI-TOF mass spectrometry. Anal. Chem. 75, 3385-3395
29. Yanes, O., Villanueva, J., Querol, E., and Aviles, F. X. (2004) Intensity-fading MALDI-TOF-MS: novel screening for ligand binding and drug discovery. Drug Discov. Today: TARGETS 3, Suppl. 1, 23-30
30. de Eguileor, M., Tettamanti, G., Grimaldi, A., Congiu, T., Ferrarese, R., Perletti, G., Valvassori, R., and Cooper, E. L. (2003) Leeches: immune response, angiogenesis and biomedical applications. Curr. Pharm. Des. 9, 133-147
31. Salzet, M. (2002) Leech thrombin inhibitors. Curr. Pharm. Des. 8, 493-503
32. Schoofs, L., Clynen, E., and Salzet, M. (2002) Trypsin and chymotrypsin inhibitors in insects and gut leeches. Curr. Pharm. Des. 8, 483-491
33. Salzet, M. (2001) Anticoagulants and inhibitors of platelet aggregation derived from leeches. FEBS Lett. 492, 187-192
34. Villanueva, J., Canals, F., Querol, E., and Aviles, F. X. (2001) Monitoring the expression and purification of recombinant proteins by MALDI-TOF mass spectrometry. Enzyme Microb. Technol. 5, 99-103
35. Ako, H., Foster, R. J., and Ryan, C. A. (1974) Mechanism of action of naturally occurring proteinase-inhibitors - studies with anhydrotrypsin and anhydrochymotrypsin purified by affinity chromatography. Biochemistry. 13, 132-139
36. Feinstein, G., and Feeney, R. E. (1966) Interaction of inactive derivatives of chymotrypsin and trypsin with protein inhibitors. J. Biol. Chem. 241, 5183-5189
37. Hillenkamp, F., and Karas, M. (1988) Laser desorption ionization of proteins with molecular masses exceeding 10000 daltons. Anal. Chem. 60, 2299-2301
38. Karas, M., and Kruger, R. (2003) Ion formation in MALDI: the cluster ionization mechanism. Chem. Rev. 103, 427-440
39. Knochenmuss, R., Stortelder, A., Breuker, K., and Zenobi, R. (2000) Secondary ion-molecule reactions in matrix-assisted laser desorption/ionization. J. Mass Spectrom. 35, 1237-1245
40. Knochenmuss, R., and Zenobi, R. (2003) MALDI ionization: the role of in-plume processes. Chem. Rev. 103, 441-452
41. Reverter, D., Vendrell, J., Canals, F., Horstmann, J., Avilés, F. X., Fritz, H., and Sommerhoff, C. P. (1998) A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization. J. Biol. Chem. 273, 32927-32933
42. Babin, D. R., Peanasky, R. J., and Goos, S. M. (1984) The isoinhibitors of chymotrypsin elastase from ascaris-lumbricoides - the primary structure. Arch. Biochem. Biophys. 232, 143-161
43. Knecht, R., Seemüller, U., Liersch, M., Fritz, H., Braun, D. G., and Chang, J. Y. (1983) Sequence determination of eglin C using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation. Anal. Biochem. 130, 65-71
44. Kim, K. Y., Lim, H. K., Lee, K. J., Park, D. H., Kang, K. W., Chung, S. I., and Jung, K. H. (2000) Production and characterization of recombinant guamerin, an elastase-specific inhibitor, in the methylotrophic yeast Pichia pastoris. Protein Expr. Purif. 20, 1-9
45. Jung, H. I., Kim, S. I., He, K. S., Joe, C. O., and Kang, K. W. (1995) Isolation and characterization of guamerin, a new human leukocyte elastase inhibitor from Hirudo nipponia. J. Biol. Chem. 270, 13879-13884
46. Kim, D. R., and Kang, K. W. (1998) Amino acid sequence of piguamerin, an antistasin-type protease inhibitor from the blood sucking leech Hirudo nipponia. Eur. J. Biochem. 254, 692-697
47. Moser, M., Auerswald, E., Mentele, R., Eckerskom, C., Fritz, H., and Fink, E. (1998) Bdellastasin, a serine protease inhibitor of the antistasin family from the medical leech (Hirudo medicinalis) - primary structure, expression in yeast, and characterisation of native and recombinant inhibitor. Eur. J. Biochem. 253, 212-220
48. Sollner, C., Mentele, R., Eckerskorn, C., Fritz, H., and Sommerhoff, C. P. (1994) Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis. Eur. J. Biochem. 219, 937-943
49. Ascenzi, P., Amiconi, G., Bode, W., Bolognesi, M., Colette, M., and Menegatti, E. (1995) Proteinase-inhibitors from the European medicinal leech Hirudo medicinalis structural, functional and biomedical aspects. Mol. Asp. Med. 16, 215-313
50. Rester, U., Bode, W., Moser, M., Parry, M. A., Huber, R., and Auerswald, E. (1999) Structure of the complex of the antistasin-type inhibitor bdellastasin with trypsin and modelling of the bdellastasin-microplasmin system. J. Mol. Biol. 293, 93-106
51. Hill, R. E., and Hastie, N. D. (1987) Accelerated evolution in the reactive center regions of serine protease inhibitors. Nature. 326, 96-99
52. Zang, X., and Maizels, R. M. (2001) Serine proteinase inhibitors from nematodes and the arms race between host and pathogen. Trends Biochem. Sci. 26, 191-197
53. Baskova, I. P., and Zavalova, L. L. (2001) Proteinase inhibitors from the medicinal leech Hirudo medicinalis. Biochemistry (Mosc.) 66, 703-714